NAVB

Navidea Biopharmaceuticals Inc.

Delisted

NAVB was delisted on the 5th of October, 2023.

83 hedge funds and large institutions have $100M invested in Navidea Biopharmaceuticals Inc. in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

40% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 10

79% less call options, than puts

Call options by funds: $2.6M | Put options by funds: $12.2M

Holders
83
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.6M
Puts
$12.2M
Net Calls
Net Calls Change

Top Buyers

1 +$10.1M
2 +$6.84M
3 +$4.63M
4
IG
ING Group
Netherlands
+$2.23M
5
Nomura Holdings
Nomura Holdings
Japan
+$1.31M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$26M
2
$12M
3
$10.2M
4
$8.4M
5
$7.54M
6
$6.24M
7
$5.65M
8
$3.43M
9
$2.99M
10
$2.81M
11
$2.23M
12
$1.18M
13
$1.13M
14
$881K
15
$862K
16
$645K
17
$625K
18
$545K
19
$499K
20
$453K
21
$412K
22
$400K
23
$332K
24
$317K
25
$302K